Home  »  Business   »  Attention Investors: What’s Really Happening...

Attention Investors: What’s Really Happening To Athira Pharma Inc. (NASDAQ: ATHA)

Athira Pharma Inc. (NASDAQ:ATHA) price closed higher on Friday, July 01, jumping 5.57% above its previous close.

A look at the daily price movement shows that the last close reads $3.05, with intraday deals fluctuated between $3.01 and $3.3199. Taking into account the 52-week price action we note that the stock hit a 52-week high of $16.65 and 52-week low of $2.53. The stock subtracted -64.06% on its value in the past month.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Athira Pharma Inc., which has a market valuation of $114.79 million, is expected to release its quarterly earnings report Mar 23, 2022 – Mar 28, 2022. Analysts tracking ATHA have forecast the quarterly EPS to shrink by -0.56 per share this quarter, while the same analysts predict the annual EPS to hit -$2.34 for the year 2022 and up to -$2.96 for 2023. In this case, analysts estimate an annual EPS growth of -57.00% for the year and -26.50% for the next year.

Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with 1 upward and no downward reviews. On the technical perspective front, indicators give ATHA a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.

Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 5 analysts have assigned ATHA a recommendation rating as follows: 4 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Athira Pharma Inc. (ATHA) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Hold, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.

The overview shows that ATHA’s price is at present -51.12% off the SMA20 and -61.69% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 22.56, with weekly volatility standing at 9.93%. The indicator jumps to 8.01% when calculated based on the past 30 days. Athira Pharma Inc. (NASDAQ:ATHA)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.67. Considering analysts have assigned the stock a price target range of $3.00-$51.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $19.00. Based on this estimate, we see that current price is roughly 6.83% off the estimated low and -1483.85% off the forecast high. Investors will no doubt be excited to see the share price fall to $5.00, which is the median consensus price, and at that level ATHA would be -55.28% from current price.

An analysis of the Athira Pharma Inc. (NASDAQ:ATHA) stock in terms of its daily trading volume indicates that the 3-month average is 846.46K.

Current records show that the company has 37.59M in outstanding shares. The insiders’ percentage holdings are 1.00% of outstanding shares while the percentage share held by institutions stands at 75.40%. But the -75.29% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]